BERKELEY, Calif., Nov. 5, 2015 -- XOMA Corporation (XOMA), a [...]

ALACHUA, Fla. & OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (Takeda) [...]

ALACHUA, Fla.--(BUSINESS WIRE)--Nanotherapeutics, Inc., a global manufacturer of biodefense and [...]

ALACHUA — Signs of a growing biotech industry could be [...]

An unusual federal government agency, the Biomedical Advanced Research and [...]

Nanotherapeutics, Inc., an integrated biopharmaceutical company with a focus on advanced development and manufacturing, announced today that it has secured a $28.5 million debt financing from White Oak Global Advisors, LLC. The funds will support the completion of the Company’s 180,000 sq. ft. flexible biologics manufacturing facility located in Alachua.

The NANO-ADM (Advanced Development and Manufacturing) facility, as it is known, will expand Nanotherapeutics’ core competencies in the development and cGMP manufacture of preclinical and clinical stage biopharmaceutical products. The Company provides a full range of drug development services and intends to further capitalize on its capabilities through partnerships with government and established companies, as well as continuing to fund the development of its internal pipeline.